USPTO considering deferred examination option for patent applications
By Jim Singer
The U.S. Patent and Trademark Office recently announced that it is seeking public input on whether to adopt a process that will defer examination of patent applications until the applicant submits an express request for examination.
Many foreign patent offices require patent applicants to expressly request examination before they review the applications. The reasons for deferred [...]
USPTO to Host Deferred Patent Examination Roundtable In the January 28, 2009 Federal Register, the USPTO announced that it will be hosting a roundtable event to discuss the topic of deferred patent examination. According to the Federal Register (excerpt link below), the roundtable will be held on February 12, 2009, from 9 a...
Patently-O Bits and Bytes No. 44: Deferred Examination Deferred Examination I: For the current state of PTO backlog, I am a strong believer in providing a mechanism to either (i) allowing the inventor pay to move to the front of the examination line if the patent needs to...
U.S. Patent Office to Host Roundtable on Deferred Examination. Per a press release at the U.S. Patent and Trademark Office website today: In response to suggestions from stakeholders in the intellectual property (IP) community that the USPTO adopt some form of a deferred examination procedure, the agency will conduct a public roundtable discussion on the topic on Thursday, February 12, 2009, from 9 a...
USPTO publie des documents de formation pour les examinateurs sur le written description requirement Ce matériel sera d’intérêt pour les gens en biotech entre autres puisque le document contient plusieurs exemples pratiques de revendications sur des nucléotides, etc.. Voici un extrait de l’annonce du USPTO: The United States Patent and Trademark Office (USPTO) has published updated patent examiner training materials regarding the examination of patent applications under the written description [...
Search Blog Directory:
Lawsuits and Settlements
Zantac Patent GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Federal Government Florida residents sue claiming extraordinary delays in judging citizenship applications.
Soliris Patent Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Options Backdating Former Broadcom executive settles $1.3 million stock option backdating lawsuit.
DRAM Patent ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.